Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.42 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.42 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.42 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | GPR3 | P46089 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.34 |
| ▸ | BRD7 | Q9NPI1 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12346091 | 0.93 | KDM4E (0.53) | KDM4EATML3MBTL1AKR1C4AKR1C3 | |
| SCHEMBL25693022 | 0.93 | KDM4E (0.52) | KDM4EATML3MBTL1AKR1C4AKR1C3 | |
| SCHEMBL29351241 | 0.92 | L3MBTL1 (0.52) | KDM4EATML3MBTL1AKR1C4AKR1C3 | |
| SCHEMBL4546816 | 0.92 | L3MBTL1 (0.52) | KDM4EATML3MBTL1AKR1C4AKR1C3 | |
| SCHEMBL12414454 | 0.92 | KDM4E (0.52) | KDM4EATML3MBTL1AKR1C4AKR1C3 | |
| SCHEMBL4546841 | 0.91 | KDM4E (0.50) | KDM4EATML3MBTL1AKR1C4AKR1C3 | |
| SCHEMBL13238025 | 0.91 | AKR1C4 (0.44) | KDM4EATML3MBTL1AKR1C4AKR1C3 | |
| SCHEMBL4546819 | 0.90 | L3MBTL1 (0.55) | KDM4EATML3MBTL1AKR1C4AKR1C3 | |
| SCHEMBL4546820 | 0.90 | L3MBTL1 (0.55) | KDM4EATML3MBTL1AKR1C4AKR1C3 | |
| SCHEMBL19271510 | 0.88 | L3MBTL1 (0.52) | KDM4EATML3MBTL1AKR1C4AKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8178215-B2 | Organic compound containing at least two carbazolyl-substituted phenyl structures; charge-transporting material and organic el element containing the compound | PIONEER CORPORATION (JP) | 2012-05-15 | — | — | US | disclosed |
| US-8178215-B2 | Organic compound containing at least two carbazolyl-substituted phenyl structures; charge-transporting material and organic el element containing the compound | PIONEER CORPORATION (JP) | 2012-05-15 | — | — | US | disclosed |
| US-7993763-B2 | Emissive core of an iridium atom and ligands coordinated to the metal atom; a host group with two rings or a heteroaryl group with two rings and a terminal alkyl group, a heteroalkyl group, an aryl group, or a heteroaryl group; organic phototransistors, organic photovoltaic cells | UNIVERSAL DISPLAY CORPORATION (US) | 2011-08-09 | — | — | US | disclosed |
| US-20090236973-A1 | ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT | PIONEER CORPORATION (JO) | 2009-09-24 | — | — | US | disclosed |
| US-20090236973-A1 | ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT | PIONEER CORPORATION (JO) | 2009-09-24 | — | — | US | disclosed |
| US-20080280163-A1 | Organometallic compounds having host and dopant functionalities | UNIVERSAL DISPLAY CORPORATION | 2008-11-13 | — | — | US | disclosed |
| EP-1820801-A1 | ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT | Pioneer Corporation (JP) | 2007-08-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090236973-A1 | ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT | SLCO4C1, SLCO2A1, SLCO2B1 | KDM4E 2187/4885ATM 4266/4885L3MBTL1 702/4885 |
| US-20080280163-A1 | Organometallic compounds having host and dopant functionalities | PNMT, DDT, TYR | KDM4E 3850/4885ATM 3778/4885L3MBTL1 835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.